Yiming Meng

Prof. Yiming Meng

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
YMYiming Meng
Yiming Meng
JSJing Sun
Jing Sun
GZGuirong Zhang
Guirong Zhang
Vaginal microbiota transplantation (VMT) is a cutting-edge treatment modality that has the potential to revolutionize the management of vaginal disorders. The human vagina is a complex and dynamic ecosystem home to a diverse community of microorganisms. These microorganisms play a crucial role in maintaining the health and well-being of the female reproductive system. However, when the balance of this ecosystem is disrupted, it can lead to the development of various vaginal disorders. Conventional treatments, such as antibiotics and antifungal medications, can temporarily relieve the symptoms of vaginal disorders. However, they often fail to address the underlying cause of the problem, which is the disruption of the vaginal microbiota. In recent years, VMT has emerged as a promising therapeutic approach that aims to restore the balance of the vaginal ecosystem. Several studies have demonstrated the safety and efficacy of VMT in treating bacterial vaginosis, recurrent yeast infections, and other vaginal conditions. The procedure has also shown promising results in reducing the risk of sexually transmitted infections and preterm birth in pregnant women. However, more research is needed to establish optimal donor selection, preparation, and screening protocols, as well as long-term safety and efficacy. VMT offers a safe, effective, and minimally invasive treatment option for women with persistent vaginal problems. It could improve the quality of life for millions of women worldwide and become a standard treatment option shortly. With further research and development, it could potentially treat a wide range of other health problems beyond the scope of vaginal disorders.

9 September 2023 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
YMYiming Meng
Yiming Meng
JSJing Sun
Jing Sun
GZGuirong Zhang
Guirong Zhang

4 June 2024 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
YMYiming Meng
Yiming Meng
JSJing Sun
Jing Sun
Gui-Rong ZhangGui-Rong Zhang
Gui-Rong Zhang

11 August 2025 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
YMYiming Meng
Yiming Meng
JSJing Sun
Jing Sun
YMYushu Ma
Yushu Ma
CKCuicui Kong
Cuicui Kong
The online version contains supplementary material available at 10.1186/s12951-025-03621-6. The online version contains supplementary material available at 10.1186/s12951-025-03621-6.

15 May 2023 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
YMYiming Meng
Yiming Meng
JSJing Sun
Jing Sun
GZGuirong Zhang
Guirong Zhang

9 August 2024 in Chinese Medical Journal
Verified
Journal Article
Open access
YMYiming Meng
Yiming Meng
CKCuicui Kong
Cuicui Kong
YMYushu Ma
Yushu Ma
JSJing Sun
Jing Sun
GZGuirong Zhang
Guirong Zhang
Bacterial outer membrane vesicles (OMVs) are diminutive vesicles naturally released by Gram-negative bacteria. These vesicles possess distinctive characteristics that attract attention for their potential use in drug administration and immunotherapy in cancer treatment. Therapeutic medicines may be delivered via OMVs directly to the tumor sites, thereby minimizing exposure to healthy cells and lowering the risk of systemic toxicity. Furthermore, the activation of the immune system by OMVs has been demonstrated to facilitate the recognition and elimination of cancer cells, which makes them a desirable tool for immunotherapy. They can also be genetically modified to carry specific antigens, immunomodulatory compounds, and small interfering RNAs, enhancing the immune response to cancerous cells and silencing genes associated with disease progression. Combining OMVs with other cancer treatments like chemotherapy and radiation has shown promising synergistic effects. This review highlights the crucial role of bacterial OMVs in cancer, emphasizing their potential as vectors for novel cancer targeted therapies. As researchers delve deeper into the complexities of these vesicles and their interactions with tumors, there is a growing sense of optimism that this avenue of study will bring positive outcomes and renewed hope to cancer patients in the foreseeable future.